Small Molecules

07 Mar 2018 Esperion Announces Positive Top-Line Results from First Pivotal Phase 3 Study of Bempedoic Acid
07 Mar 2018 Merck KGaA, Darmstadt, Germany, Announces Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis
07 Mar 2018 Sunovion Receives FDA Approval of Supplemental New Drug Application (sNDA) for Use of Latuda® (lurasidone HCl) in the Treatment of Bipolar Depression in Pediatric Patients (10 to 17 Years of Age)
07 Mar 2018 Eisai and Purdue Pharma announce positive topline results from key clinical studies of lemborexant including first-ever phase 3 head-to-head superiority comparison versus zolpidem ER in patients with sleep disorder
07 Mar 2018 Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials
06 Mar 2018 Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Epitinib in Glioblastoma in China
06 Mar 2018 Biohaven Enrolls First Patient In Phase 3 Clinical Trial To Evaluate Rimegepant Zydis® ODT In The Acute Treatment Of Migraine
06 Mar 2018 Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Stroke Recovery
06 Mar 2018 G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer
06 Mar 2018 Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis
06 Mar 2018 U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
06 Mar 2018 Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis
06 Mar 2018 HETLIOZ® (tasimelteon) Demonstrates Efficacy to Treat Jet Lag Disorder in an 8 Hour Phase Advance Clinical Study
06 Mar 2018 Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
05 Mar 2018 Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope Targeting Antibody in SHIV-Infected, Virally Suppressed Monkeys
05 Mar 2018 The European Medicines Agency accepts regulatory submission for Forxiga in adults with type-1 diabetes
05 Mar 2018 Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
03 Mar 2018 Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
03 Mar 2018 INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms
03 Mar 2018 Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa
02 Mar 2018 Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients With Mitochondrial Myopathies
02 Mar 2018 Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients
02 Mar 2018 Vertex Initiates Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation
01 Mar 2018 Concert Pharmaceuticals Announces Advancement of Novel Drug Candidate in Schizophrenia
01 Mar 2018 Singapore eDevelopment (SGX:40V) biomedical subsidiary confirms LB2 efficacy against Ebola

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing